A 7-month-old girl with no medical history was treated with mechanical circulatory support due to myocarditis. Her cardiac contractility did not improve despite more than one week of extracorporeal membrane oxygenation treatment. Thus, we planned a heart transplant. However, a high level of cytomegalovirus was found in blood laboratory results by quantitative polymerase chain reaction. The patient's heart contractility recovered to normal range four days after ganciclovir treatment. She was discharged with slightly decreased cardiac contractility with a left ventricular ejection fraction of 45%.
A 7-month-old girl with no medical history was treated with mechanical circulatory support due to myocarditis. Her cardiac contractility did not improve despite more than one week of extracorporeal membrane oxygenation treatment. Thus, we planned a heart transplant. However, a high level of cytomegalovirus was found in blood laboratory results by quantitative polymerase chain reaction. The patient's heart contractility recovered to normal range four days after ganciclovir treatment. She was discharged with slightly decreased cardiac contractility with a left ventricular ejection fraction of 45%. During the mechanical circulatory support of almost two weeks, there was little improvement of heart contractility.
Because of deteriorating oxygenator function and worsening hyperbilirubinemia, we decide to stop ECMO with maximal inotropic support. The duration of ECMO support was 324
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− 201 − hours. During follow-up of whole blood laboratory results, CMV titer revealed a higher level than in a previous result (6,250 copies/mL). Because the CMV titer increased nine times within two weeks and there was no evidence of other disease, we decided to start intravenous ganciclovir at 2.5 mg/kg twice a day. Two days after ganciclovir treatment, LVEF improved to 35%. Heart contractility recovered to normal range four days after. Thus, we continued to use ganciclovir treatments for two weeks in total. After two weeks of treatment, CMV PCR titer decreased to normal range and LVEF recovered to 46%. However, one week after ganciclovir stopped, follow-up CMV PCR titer in the urine was still high (＞ 1,150 copies/mL), so another two weeks of ganciclovir treatment was applied and CMV PCR titer returned to normal.
Even though the hospital course of the patient was continued over three months due to renal failure and ventilator-associated pneumonia, a low CMV titer and recovered heart function remained until discharge. The duration of hospital stay was 109 days. Follow-up echocardiography 14 months later showed recovered cardiac contractility with LVEF of 64%
and decreased heart size in chest radiography.
DISCUSSION
Myocarditis is defined as an inflammation of the heart muscle, and it can lead to myocardial dysfunction. passive transmission of a maternal antibody [6] . The PCR results of other known causes of viral myocarditis were all negative and a bacterial culture study was also negative.
Though we did not perform myocardium biopsy, the negative result from the other study was enough to diagnose CMV myocarditis. In contrast to other types of viral myocarditis, the use of an antiviral agent is a feasible treatment choice for CMV myocarditis.
If the opportunity to recover LVEF was lost due to a delay in ganciclovir treatment, the only treatment option for the patient would have been heart transplantation, and heart transplantation for this patient would have been an inappropriate treatment.
Mechanical circulatory support is necessary for both fulminant myocarditis and severe dilated cardiomyopathy [2] .
Temporary mechanical circulatory support can buy time for myocardial recovery or bridge to transplantation [3] . In this case, initial cardiac function was impaired and insufficient for maintaining blood pressure; therefore, ECMO was applied.
This enabled us to buy time for exact diagnosis and allowed for slight myocardial recovery.
Ganciclovir has a dramatic effect on CMV myocarditis [1, 4, 7] . Improvement of LVEF was achieved in two days, and it reached normal values within five days of therapy. 
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